Delivery Order SPE2DB24D1104-SPE2DB24FXUV9
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $24,122.49, is for the delivery of RINVOQ ER 15 MG TABLET, a prescription medication. The IDC held by Cencora, Inc. is valued at up to $999,999,999.00 and runs through December 2025, serving as the primary vehicle for the company to provide a comprehensive...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order (DO) under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The DO, valued at $29,597.45, is for the delivery of the pharmaceutical product RINVOQ ER 15 MG TABLET. The IDC, valued at up to $999,999,999, serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $8,383.92 for the pharmaceutical product RINVOQ ER 15 MG TABLET. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a civilian agency that supports the Department of Defense's healthcare needs. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $10,714.94 for the supply of RINVOQ ER 15 MG TABLET products. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, a major healthcare provider for the Department of Defense. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $8,367.67 for the supply of RINVOQ ER 15 MG TABLET UU 30S. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, and does not have a set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of pharmaceutical products and medical supplies, including the prescription drug RINVOQ ER 45 MG TABLET. The award, valued at $9,030.57, was made by the Defense Logistics Agency (DLA) Troop Support Medical, which is part of the U.S. Department of Defense. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This federal contract award, valued at $21,559.89, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order that falls under an Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999.00, which runs through December 2025. The contract provides for the delivery of RINVOQ ER 15 MG TABLET, a pharmaceutical product, to support military treatment facilities and...
- This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of pharmaceutical products. The contract, valued at $13,640.52, is a delivery order under an Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA, worth up to $999,999,999.00, to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally....
- This federal contract award, valued at $21,185.49, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order under DLA's larger Indefinite Delivery Contract (IDC) with Cencora, Inc., valued at up to $999,999,999.00 and running through December 2026. This IDC serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical supplies,...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order worth $12,143.49 for the supply of RINVOQ ER 30 MG TABLET UU 30S medical products. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a Defense agency, on December 21, 2023, with an ultimate completion date of December 22, 2023. The contract is a Firm Fixed Price arrangement. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- SPE2DB24D1104Indefinite Delivery Contract
- SPE2DB24D1104-SPE2DB24FXUV9Delivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $11,558.67 under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract covers the delivery of a pharmaceutical product, specifically RINVOQ ER 15 MG TABLET, to support military and veteran healthcare programs. This IDC, valued up to $999,999,999.00, serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical supplies to the DLA. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued up to $750,000, for similar medical products and prescription drugs. These IDCs demonstrate Cencora, Inc.'s capacity to meet the diverse pharmaceutical needs of multiple government agencies on a large scale.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.6k | 2/29/24 |